No Data
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Yahong Pharmaceutical: Jiangsu Yahong Pharmaceutical Technology Co., Ltd. 2024 Annual Performance Report Announcement
Jiangsu Yahong Pharmaceutical Technology Co., Ltd. 2024 Annual Performance Report Announcement
Is Jiangsu Yahong Meditech (SHSE:688176) A Risky Investment?
Yahong Medicine (688176.SH): The clinical trial analysis results of APL-1202 were selected for the 2025 USA Oncology Conference.
Yahong Pharmaceutical (688176.SH) announced that the company's APL-1202 oral combination with Trelagliptin is undertaken...
Yahong Pharmaceutical (688176.SH) has newly confirmed Sun Longwei and Sun Qiaoling as core technical personnel.
Yahong Pharmaceutical (688176.SH) announced that the company's core technical staff YUSHEN GUO ...
